LakeShore Biopharma (LSB) Competitors $0.83 -0.02 (-2.10%) As of 01:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LSB vs. RPTX, IVVD, GANX, INKT, COEP, MNOV, GNTA, ADVM, CUE, and ALGSShould you be buying LakeShore Biopharma stock or one of its competitors? The main competitors of LakeShore Biopharma include Repare Therapeutics (RPTX), Invivyd (IVVD), Gain Therapeutics (GANX), MiNK Therapeutics (INKT), Coeptis Therapeutics (COEP), MediciNova (MNOV), Genenta Science (GNTA), Adverum Biotechnologies (ADVM), Cue Biopharma (CUE), and Aligos Therapeutics (ALGS). These companies are all part of the "pharmaceutical products" industry. LakeShore Biopharma vs. Its Competitors Repare Therapeutics Invivyd Gain Therapeutics MiNK Therapeutics Coeptis Therapeutics MediciNova Genenta Science Adverum Biotechnologies Cue Biopharma Aligos Therapeutics LakeShore Biopharma (NASDAQ:LSB) and Repare Therapeutics (NASDAQ:RPTX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, media sentiment, profitability and earnings. Does the media favor LSB or RPTX? In the previous week, LakeShore Biopharma and LakeShore Biopharma both had 2 articles in the media. Repare Therapeutics' average media sentiment score of 1.64 beat LakeShore Biopharma's score of 0.60 indicating that Repare Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LakeShore Biopharma 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Repare Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has higher valuation & earnings, LSB or RPTX? LakeShore Biopharma has higher revenue and earnings than Repare Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLakeShore Biopharma$614.96M0.03-$13.93MN/AN/ARepare Therapeutics$250K286.97-$84.69M-$2.58-0.65 Is LSB or RPTX more profitable? LakeShore Biopharma's return on equity of 0.00% beat Repare Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets LakeShore BiopharmaN/A N/A N/A Repare Therapeutics N/A -78.25%-66.85% Which has more risk & volatility, LSB or RPTX? LakeShore Biopharma has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Comparatively, Repare Therapeutics has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Do institutionals and insiders hold more shares of LSB or RPTX? 52.6% of LakeShore Biopharma shares are held by institutional investors. Comparatively, 85.1% of Repare Therapeutics shares are held by institutional investors. 11.5% of Repare Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Do analysts recommend LSB or RPTX? Repare Therapeutics has a consensus price target of $4.50, indicating a potential upside of 169.46%. Given Repare Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Repare Therapeutics is more favorable than LakeShore Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LakeShore Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Repare Therapeutics 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryRepare Therapeutics beats LakeShore Biopharma on 8 of the 12 factors compared between the two stocks. Get LakeShore Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LSB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LSB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LSB vs. The Competition Export to ExcelMetricLakeShore BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.20M$3.09B$5.75B$9.85BDividend YieldN/A2.28%6.66%4.49%P/E RatioN/A20.8882.7926.52Price / Sales0.03369.93499.49162.43Price / CashN/A43.5325.7028.92Price / Book0.258.0310.786.50Net Income-$13.93M-$53.35M$3.28B$266.34M7 Day Performance3.50%-1.05%-0.42%-1.25%1 Month Performance14.13%5.84%6.47%3.30%1 Year Performance-82.38%10.76%49.47%23.59% LakeShore Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LSBLakeShore Biopharma1.3755 of 5 stars$0.83-2.1%N/A-81.2%$17.20M$614.96M0.00773Short Interest ↓RPTXRepare Therapeutics3.4826 of 5 stars$1.61+1.9%$4.50+179.5%-38.8%$67.88M$53.48M-0.62180News CoverageHigh Trading VolumeIVVDInvivyd4.0138 of 5 stars$1.03+84.0%$3.18+209.1%+22.1%$67.24M$46.21M-1.12100High Trading VolumeGANXGain Therapeutics2.8402 of 5 stars$1.92+4.3%$7.80+306.3%+84.6%$66.14M$50K-3.0520INKTMiNK Therapeutics1.783 of 5 stars$15.15+4.0%$37.50+147.5%+71.6%$65.90MN/A-5.2630Positive NewsShort Interest ↑COEPCoeptis Therapeutics1.471 of 5 stars$13.21-3.2%N/A+222.7%$65.82M$263.56K-2.282Short Interest ↓MNOVMediciNova1.9343 of 5 stars$1.36+3.0%$7.00+414.7%-20.5%$64.74M$1M-5.4410News CoverageGap UpGNTAGenenta Science2.6839 of 5 stars$3.52+0.9%$25.00+610.2%-9.3%$63.83MN/A0.007Gap DownADVMAdverum Biotechnologies3.2934 of 5 stars$3.16+4.3%$19.75+525.0%-51.9%$63.48M$1M-0.40190CUECue Biopharma1.3336 of 5 stars$0.84+2.7%N/A+20.6%$62.88M$9.29M-1.5060ALGSAligos Therapeutics4.3595 of 5 stars$10.98+7.5%$50.00+355.4%-9.8%$62.81M$3.94M-0.5590Gap Down Related Companies and Tools Related Companies Repare Therapeutics Competitors Invivyd Competitors Gain Therapeutics Competitors MiNK Therapeutics Competitors Coeptis Therapeutics Competitors MediciNova Competitors Genenta Science Competitors Adverum Biotechnologies Competitors Cue Biopharma Competitors Aligos Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LSB) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LakeShore Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share LakeShore Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LSB Stock Alerts